P1102: a phase 1 study of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated b-cell lymphoma (citadel-112): preliminary safety results
HemaSphere（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要